Japan's PMDA revises precautions for multiple products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1661卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33292-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[21] Japan's PMDA presents investigation results
Reactions Weekly, 2015, 1581 (1) : 7 - 7
[22] Investigation results from Japan's PMDA
Reactions Weekly, 2016, 1630 (1) : 1 - 1
[23] Japan PMDA's investigation results for May 2019
Reactions Weekly, 2019, 1753 (1) : 3 - 3
[24] Japan's PMDA investigation results for March 2019
Reactions Weekly, 2019, 1747 (1) : 2 - 2
[25] Japan's PMDA investigation results for February 2018
Reactions Weekly, 2018, 1690 (1) : 2 - 2
[26] Recent investigation results from Japan's PMDA
Reactions Weekly, 2019, 1773 (1) : 3 - 3
[27] Japan's PMDA reviews renal contraindications for metformin
Reactions Weekly, 2019, 1767 (1) : 1 - 1
[28] Japan's PMDA investigation results: June 2018
Reactions Weekly, 2018, 1706 (1) : 4 - 4
[29] The PMDA's view on the limited pipeline of nephrology drugs in Japan
Tanaka, Mototsugu
Ikuma, Mutsuhiro
KIDNEY INTERNATIONAL, 2021, 100 (01) : 241 - 242
[30] Japan's PMDA releases updated risk report for telaprevir
Reactions Weekly, 2012, 1408 (1) : 2 - 2

← 1 2 3 4 5 →